These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 13575682

  • 1. An alternative mechanism for the properdin system.
    NELSON RA.
    J Exp Med; 1958 Oct 01; 108(4):515-35. PubMed ID: 13575682
    [Abstract] [Full Text] [Related]

  • 2. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS.
    WARD PA, COCHRANE CG.
    J Exp Med; 1965 Feb 01; 121(2):215-34. PubMed ID: 14264268
    [Abstract] [Full Text] [Related]

  • 3. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
    Brade V, Bentley C, Bitter-Suermann D, Hadding U.
    Z Immunitatsforsch Immunobiol; 1977 Feb 01; 152(5):402-14. PubMed ID: 556571
    [Abstract] [Full Text] [Related]

  • 4. Isolation and characterization of Guinea pig properidin.
    Nicholson A, Austen KF.
    J Immunol; 1977 Jan 01; 118(1):103-8. PubMed ID: 830742
    [Abstract] [Full Text] [Related]

  • 5. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA.
    J Exp Med; 1957 May 01; 105(5):403-15. PubMed ID: 13428911
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the mechanism of solubilization of immune precipitates by serum.
    Czop J, Nussenzweig V.
    J Exp Med; 1976 Mar 01; 143(3):615-30. PubMed ID: 1249522
    [Abstract] [Full Text] [Related]

  • 11. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V, Nicholson A, Lee GD, Mayer MM.
    J Immunol; 1974 May 01; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W, Schmidt G, Lynen R, Dieminger L.
    J Immunol; 1975 Feb 01; 114(2 Pt 1):671-7. PubMed ID: 804510
    [Abstract] [Full Text] [Related]

  • 14. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH, Townsend K, Michael AF.
    Clin Exp Immunol; 1975 Mar 01; 19(3):435-44. PubMed ID: 1204244
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin.
    OSLER AG, RANDALL HG, HILL BM, OVARY Z.
    J Exp Med; 1959 Aug 01; 110(2):311-39. PubMed ID: 13673141
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. EXPERIMENTAL GLOMERULONEPHRITIS. IV. PARTICIPATION OF COMPLEMENT IN NEPHROTOXIC NEPHRITIS.
    UNANUE E, DIXON FJ.
    J Exp Med; 1964 Jan 01; 119(6):965-82. PubMed ID: 14176294
    [Abstract] [Full Text] [Related]

  • 20. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.
    Marcus RL, Shin HS, Mayer MM.
    Proc Natl Acad Sci U S A; 1971 Jun 01; 68(6):1351-4. PubMed ID: 5288385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.